vs
ICU MEDICAL INC（ICUI）与STARWOOD PROPERTY TRUST, INC.（STWD）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是STARWOOD PROPERTY TRUST, INC.的1.1倍（$540.7M vs $492.9M），STARWOOD PROPERTY TRUST, INC.净利率更高（19.7% vs -2.9%，领先22.6%），STARWOOD PROPERTY TRUST, INC.同比增速更快（8.5% vs -14.1%），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -2.9%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
喜达屋酒店及度假村国际集团是全球规模最大的酒店企业之一，业务涵盖酒店、度假村、水疗中心、住宅及度假产权物业的持有、运营、特许经营与管理。集团前身为1969年成立的房地产投资信托基金，1995年完成收购重组，旗下共11个品牌，管理及特许经营的物业共计1297处。
ICUI vs STWD — 直观对比
营收规模更大
ICUI
是对方的1.1倍
$492.9M
营收增速更快
STWD
高出22.6%
-14.1%
净利率更高
STWD
高出22.6%
-2.9%
两年增速更快
ICUI
近两年复合增速
-2.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $492.9M |
| 净利润 | $-15.7M | $96.9M |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | 26.6% |
| 净利率 | -2.9% | 19.7% |
| 营收同比 | -14.1% | 8.5% |
| 净利润同比 | 34.0% | 87.7% |
| 每股收益（稀释后） | $-0.63 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUISTWD
| Q4 25 | $540.7M | $492.9M | ||
| Q3 25 | $537.0M | $488.9M | ||
| Q2 25 | $548.9M | $444.3M | ||
| Q1 25 | $604.7M | $418.2M | ||
| Q4 24 | $629.8M | $454.4M | ||
| Q3 24 | $589.1M | $479.5M | ||
| Q2 24 | $596.5M | $489.8M | ||
| Q1 24 | $566.7M | $523.1M |
净利润ICUISTWD
| Q4 25 | $-15.7M | $96.9M | ||
| Q3 25 | $-3.4M | $72.6M | ||
| Q2 25 | $35.3M | $129.8M | ||
| Q1 25 | $-15.5M | $112.3M | ||
| Q4 24 | $-23.8M | $51.6M | ||
| Q3 24 | $-33.0M | $76.1M | ||
| Q2 24 | $-21.4M | $77.9M | ||
| Q1 24 | $-39.5M | $154.3M |
毛利率ICUISTWD
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
营业利润率ICUISTWD
| Q4 25 | 1.0% | 26.6% | ||
| Q3 25 | 2.6% | 19.1% | ||
| Q2 25 | 1.9% | 30.5% | ||
| Q1 25 | 2.1% | 28.7% | ||
| Q4 24 | 6.0% | 15.1% | ||
| Q3 24 | 1.4% | 17.2% | ||
| Q2 24 | 1.3% | 19.1% | ||
| Q1 24 | -1.9% | 30.8% |
净利率ICUISTWD
| Q4 25 | -2.9% | 19.7% | ||
| Q3 25 | -0.6% | 14.8% | ||
| Q2 25 | 6.4% | 29.2% | ||
| Q1 25 | -2.6% | 26.8% | ||
| Q4 24 | -3.8% | 11.4% | ||
| Q3 24 | -5.6% | 15.9% | ||
| Q2 24 | -3.6% | 15.9% | ||
| Q1 24 | -7.0% | 29.5% |
每股收益（稀释后）ICUISTWD
| Q4 25 | $-0.63 | $0.25 | ||
| Q3 25 | $-0.14 | $0.19 | ||
| Q2 25 | $1.43 | $0.38 | ||
| Q1 25 | $-0.63 | $0.33 | ||
| Q4 24 | $-0.97 | $0.15 | ||
| Q3 24 | $-1.35 | $0.23 | ||
| Q2 24 | $-0.88 | $0.24 | ||
| Q1 24 | $-1.63 | $0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $499.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $6.8B |
| 总资产 | $4.1B | $63.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUISTWD
| Q4 25 | — | $499.5M | ||
| Q3 25 | — | $301.1M | ||
| Q2 25 | — | $259.9M | ||
| Q1 25 | — | $440.6M | ||
| Q4 24 | $308.6M | $377.8M | ||
| Q3 24 | $312.5M | $357.9M | ||
| Q2 24 | $302.6M | $259.3M | ||
| Q1 24 | $251.4M | $327.4M |
股东权益ICUISTWD
| Q4 25 | $2.1B | $6.8B | ||
| Q3 25 | $2.1B | $6.9B | ||
| Q2 25 | $2.1B | $6.4B | ||
| Q1 25 | $2.0B | $6.4B | ||
| Q4 24 | $2.0B | $6.4B | ||
| Q3 24 | $2.0B | $6.5B | ||
| Q2 24 | $2.0B | $6.2B | ||
| Q1 24 | $2.1B | $6.3B |
总资产ICUISTWD
| Q4 25 | $4.1B | $63.2B | ||
| Q3 25 | $4.1B | $62.4B | ||
| Q2 25 | $4.1B | $62.4B | ||
| Q1 25 | $4.2B | $62.2B | ||
| Q4 24 | $4.2B | $62.6B | ||
| Q3 24 | $4.3B | $64.2B | ||
| Q2 24 | $4.3B | $64.1B | ||
| Q1 24 | $4.3B | $66.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $488.8M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.6% | — |
| 现金转化率经营现金流/净利润 | — | 5.04× |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUISTWD
| Q4 25 | $60.6M | $488.8M | ||
| Q3 25 | $56.7M | $337.6M | ||
| Q2 25 | $11.2M | $-87.4M | ||
| Q1 25 | $51.3M | $238.9M | ||
| Q4 24 | $40.2M | $295.6M | ||
| Q3 24 | $36.1M | $241.8M | ||
| Q2 24 | $82.0M | $53.3M | ||
| Q1 24 | $45.8M | $55.9M |
自由现金流ICUISTWD
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $62.5M | — | ||
| Q1 24 | $29.9M | — |
自由现金流率ICUISTWD
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | 5.3% | — |
资本支出强度ICUISTWD
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 2.8% | — |
现金转化率ICUISTWD
| Q4 25 | — | 5.04× | ||
| Q3 25 | — | 4.65× | ||
| Q2 25 | 0.32× | -0.67× | ||
| Q1 25 | — | 2.13× | ||
| Q4 24 | — | 5.72× | ||
| Q3 24 | — | 3.18× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | 0.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
STWD
| Commercial And Residential Lending Segment | $335.2M | 68% |
| Infrastructure Lending Segment | $70.3M | 14% |
| Property Segment | $57.8M | 12% |
| Other | $29.7M | 6% |
